Nevro Corp (NVRO)
4.52
+0.16
(+3.67%)
USD |
NYSE |
Nov 22, 16:00
4.515
0.00 (0.00%)
After-Hours: 20:00
Nevro Cash from Operations (Quarterly): 2.732M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.732M |
June 30, 2024 | -8.11M |
March 31, 2024 | -32.66M |
December 31, 2023 | -8.923M |
September 30, 2023 | -6.09M |
June 30, 2023 | -14.50M |
March 31, 2023 | -29.31M |
December 31, 2022 | -13.42M |
September 30, 2022 | 79.35M |
June 30, 2022 | -12.83M |
March 31, 2022 | -28.42M |
December 31, 2021 | -15.16M |
September 30, 2021 | -15.36M |
June 30, 2021 | -4.489M |
March 31, 2021 | -6.871M |
December 31, 2020 | 11.86M |
September 30, 2020 | 11.34M |
June 30, 2020 | -16.82M |
March 31, 2020 | -5.181M |
December 31, 2019 | -13.48M |
September 30, 2019 | -3.373M |
June 30, 2019 | -11.67M |
Date | Value |
---|---|
March 31, 2019 | -21.71M |
December 31, 2018 | 5.00M |
September 30, 2018 | -5.596M |
June 30, 2018 | 1.126M |
March 31, 2018 | -6.238M |
December 31, 2017 | -2.443M |
September 30, 2017 | 5.416M |
June 30, 2017 | -3.479M |
March 31, 2017 | -13.77M |
December 31, 2016 | -15.64M |
September 30, 2016 | -1.931M |
June 30, 2016 | -10.66M |
March 31, 2016 | -30.26M |
December 31, 2015 | -30.42M |
September 30, 2015 | -29.40M |
June 30, 2015 | -23.78M |
March 31, 2015 | -16.83M |
December 31, 2014 | -9.148M |
September 30, 2014 | -6.92M |
June 30, 2014 | -6.98M |
March 31, 2014 | -8.10M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-32.66M
Minimum
Mar 2024
79.35M
Maximum
Sep 2022
-6.318M
Average
-10.88M
Median
Cash from Operations (Quarterly) Benchmarks
Inspire Medical Systems Inc | 52.28M |
Inari Medical Inc | 2.712M |
Stereotaxis Inc | -4.329M |
Electromed Inc | 2.309M |
Myomo Inc | -1.494M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -6.435M |
Cash from Financing (Quarterly) | -0.354M |
Free Cash Flow | -56.61M |
Free Cash Flow Per Share (Quarterly) | 0.0043 |
Free Cash Flow to Equity (Quarterly) | -3.71M |
Free Cash Flow to Firm (Quarterly) | 4.013M |
Free Cash Flow Yield | -34.08% |